Genprex, Inc. Cash Flow Statement
GNPX|6 years of annual SEC 10-K data (FY2017-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
Genprex, Inc. used $25M in operating cash flow in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Net Income | -$30.9M | -$23.7M | -$20.7M | -$17.9M | -$3.3M | -$4.1M |
| Depreciation & Amortization | $15.0K | $25.6K | $22.5K | $22.8K | $3.2K | $862 |
| Operating Cash Flow | -$24.7M | -$17.6M | -$14.3M | -$13.9M | -$2.2M | -$1.2M |
| Capital Expenditures | - | - | $31.7K | $17.6K | $5.9K | $5.0K |
| Free Cash Flow | - | - | -$14.3M | -$14.0M | -$2.2M | -$1.3M |